Evidence map›Paper›PMID 42773458›Full record

ArticleJournal of translational medicine2026

Horizontal mitochondrial transfer and mitochondrial transplantation in skin: protection against UVR-induced ROS damage and enhancement of cell proliferation and wound healing.

Andrés Caicedo, Abigail Benavides-Almeida, Sebastián Peñaherrera, Paola Robayo, Andrés Villagómez, Matheo León, Andrés Suárez-Usbeck, Santiago D Padilla-Sánchez, Martin Santacruz, Tatiana Borja and 32 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Andrés CaicedoUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador. acaicedo@usfq.edu.ec.ORCID http://orcid.org/0000-0001-8821-0333
Abigail Benavides-AlmeidaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Sebastián PeñaherreraUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Paola RobayoUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Andrés VillagómezUniversidad San Francisco de Quito USFQ, Escuela de Medicina Veterinaria, Quito, Ecuador.
Matheo LeónUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.
Andrés Suárez-UsbeckUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.
Santiago D Padilla-SánchezUniversidad San Francisco de Quito USFQ, Escuela de Medicina Veterinaria, Quito, Ecuador.
Martin SantacruzUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Tatiana BorjaServicio de Patología, Hospital Vozandes, Quito, Ecuador.
María Belén ArteagaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Alissen Haro-VinuezaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Gilberto SegniniUniversidad San Francisco de Quito USFQ, Escuela de Medicina Veterinaria, Quito, Ecuador.
Patricia PontónServicio de Patología, Hospital Vozandes, Quito, Ecuador.
Fernando TorresUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Gustavo DonosoUniversidad San Francisco de Quito USFQ, Escuela de Medicina Veterinaria, Quito, Ecuador.
Daniela SuquilloUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Lucas Ferreira Dos SantosLaboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, Brazil.
Pamela ArizoUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.
Domenica TenesacaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Barbara AntilefMolecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepción, Concepción, Chile.
Gabriela ZavalaIMPACT, Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Santiago, Chile.
Diego BarbaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Luciano FerradaMolecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepción, Concepción, Chile.
Andrea Del CampoFacultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Kevin ZambranoUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Sebastian Chile-MirandaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Cynthia Viera-CatotaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Solange CisternaMolecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepción, Concepción, Chile.
Diego VillavicencioUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Álvaro A Pérez-MezaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias de la Salud, Escuela de Medicina, Quito, Ecuador.
Diego F Cisneros-HerediaUniversidad San Francisco de Quito USFQ, Colegio de Ciencias Biológicas y Ambientales, Quito, Ecuador.
Pedro M AponteUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.
Francisco CabreraUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.
Patricia Luz-CrawfordMito-Act Research Consortium, Quito, Ecuador.
Iván M MoyaMito-Act Research Consortium, Quito, Ecuador.
Maria Ines MitraniMito-Act Research Consortium, Quito, Ecuador.
Maroun KhouryMito-Act Research Consortium, Quito, Ecuador.
Estefanía Nova-LampertiMito-Act Research Consortium, Quito, Ecuador.
Verónica A BurzioMito-Act Research Consortium, Quito, Ecuador.
Tatiana Maron-GutierrezMito-Act Research Consortium, Quito, Ecuador.
Ramiro F DíazUniversidad San Francisco de Quito USFQ, Instituto de Investigaciones en Biomedicina iBiomed, Quito, Ecuador.

Funding

AFOSR FA9550-20-1-0407CEDIA CEPRA XIV-2020-04
6 · The paper itself

Abstract

backgroundSkin homeostasis, protection against ultraviolet radiation (UVR), and wound repair depend on coordinated interactions among melanocytes, keratinocytes, and fibroblasts. Horizontal mitochondrial transfer (HMT) is a naturally occurring form of intercellular communication in which mitochondria move between cells and may contribute to stress adaptation, cellular recovery, and tissue resilience. Artificial mitochondrial transfer (AMT), performed in vitro or ex vivo, and mitochondrial transplantation (MT), involving the direct administration of isolated mitochondria in vivo, seek to therapeutically harness these biological mechanisms. However, HMT among resident skin cells and its relationship to mitochondria-based regenerative strategies remain poorly understood.

methodsHMT among human melanocytes, keratinocytes, and fibroblasts was evaluated under basal conditions and following UVR exposure. Direct 2D coculture and transwell systems were used to assess predominantly contact-dependent and contact-independent HMT, respectively, using fluorescence microscopy. AMT was performed by delivering isolated mitochondria from human fibroblast, human Wharton's jellymesenchymal stem/stromal cells (WJ-MSCs), or mouse bone marrow MSCs (BM-MSCs) to recipient fibroblasts, followed by assessment of mitochondrial uptake, reactive oxygen species (ROS) production, and cell proliferation. The regenerative effects of locally administered MSC-derived mitochondria were subsequently evaluated in murine and porcine primary-intention wound models: mouse BM-MSC-derived mitochondria were used in murine wounds, whereas human WJ-MSC-derived mitochondria were used in porcine wounds. Outcomes were assessed using histological analysis, the wound healing index (WHI), and, in pigs, spatial quantification of Ki67-positive cells.

resultsHMT from melanocytes to keratinocytes increased significantly after UVR exposure and occurred predominantly under direct coculture conditions, reaching approximately 39%, compared with less than 9% in transwell assays. HMT in the other donor-recipientcombinationsremainedbelow4%.AMTusing human WJ-MSC-derived mitochondria reduced UVR-induced ROS production, while mitochondria derived from both human WJ-MSCs and mouse BM-MSCs significantly increased fibroblast proliferation, although the magnitude of these effects depended on the mitochondrial dose. In murine wounds, locally administered BM-MSC-derived mitochondria enhanced early histological repair and produced effects comparable to those observed after intact BM-MSC administration. In porcine wounds, WJ-MSC-derived mitochondria increased the WHI, improved collagen-containing tissue organization, and enhanced Ki67 positivity within epidermal and dermal regions directly involved in wound repair.

conclusionsThese findings identify HMT as a cell-type-specific response in the skin, with preferential HMT from melanocytes to keratinocytes that is enhanced by UVR exposure. They also demonstrate that MSC-derived mitochondria can reduce oxidative stress, stimulate fibroblast proliferation, and promote early cutaneous repair after local administration. Together, the results establish a translational link between endogenous mitochondrial exchange and the therapeutic use of AMT and MT, supporting further development of mitochondria-based, cell-free strategies for skin injury and impaired wound healing.

Indexed as

MitochondriaReactive Oxygen SpeciesSkinUltraviolet RaysWound HealingAnimalsCell ProliferationFibroblastsHumansKeratinocytesMelanocytesMesenchymal Stem CellsMiceReactive Oxygen SpeciesArtificial Mitochondrial Transfer (AMT)Artificial Mitochondrial Transfer/Transplant (AMT/T)FibroblastHorizontal Mitochondrial Transplant (HMT)KeratinocytesMelanocytesMitochondriaMitochondrial Transplant (MT)Reactive Oxygen Species (ROS)RegenerationRepairSkinUltraviolet Radiation (UVR)Wound Healing

Identifiers

PMID42773458
PMCPMC13595639

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.